Document detail

13 July 2021 The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both passive and active surveillance methods. Specific considerations and limitations of each method are provided as well as tools for implementation.

Vaccination,  COVID-19,  SARS-CoV-2,  communication,  Training manual,  Surveillance,  data management,  stakeholders,  pharmacovigilance,  safety,  Pregnancy,  breasfeeding,